Overexpression of M 3 muscarinic receptor is a novel strategy for preventing sudden cardiac death in transgenic mice

Molecular Medicine

Volumn 17, Issue 11, 2011, Pages 1179-1187

  Liu, Yan ^a   Sun, Lihua ^a   Pan, Zhenwei ^a   Bai, Yunlong ^a   Wang, Ning ^a   Zhao, Jinlong ^b   Xu, Chaoqian ^a   Li, Zhi ^a   Li, Baoxin ^a   Du, Zhimin ^b   Lu, Yanjie ^a   Gao, Xu ^b   Yang, Baofeng ^a  

^a Department of Pharmacology   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITINE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MICRORNA; MICRORNA 1; MUSCARINIC M3 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REPERFUSION; INCIDENCE; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUDDEN DEATH; WESTERN BLOTTING; WHOLE CELL;

ACONITINE; ACTION POTENTIALS; ANIMALS; CALCIUM CHANNELS; DEATH, SUDDEN, CARDIAC; GENE EXPRESSION REGULATION; HEART VENTRICLES; ION CHANNEL GATING; MICE; MICE, TRANSGENIC; MICRORNAS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; PROMOTER REGIONS, GENETIC; PROTEIN SUBUNITS; RECEPTOR, MUSCARINIC M3; RNA, MESSENGER;

EID: 82855177912     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00093     Document Type: Article

References (37)

1. Adabag AS, Luepker RV, Roger VL, Gersh BJ. (2010) Sudden cardiac death: epidemiology and risk factors. Nat. Rev. Cardiol. 7:216-25.
2. Zhang S. (2009) Sudden cardiac death in China. Pacing Clin. Electrophysiol. 32:1159-62.
3. Clements-Jewery H, Hearse DJ, Curtis MJ. (2005) Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation. Br. J. Pharmacol. 145:551-64.
4. Walker MJ. (2006) Antiarrhythmic drug research. Br. J. Pharmacol. 147 Suppl 1:S222-31.
5. Shi H, Wang H, Wang Z. (1999) Identification and characterization of multiple subtypes of muscarinic acetylcholine receptors and their physiological functions in canine hearts. Mol. Pharmacol. 55:497-507.
6. Lamping KG, Wess J, Cui Y, Nuno DW, Faraci FM. (2004) Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine. Arterioscler. Thromb. Vasc. Biol. 24:1253-8.
7. Shi H, Wang H, Li D, Nattel S, Wang Z. (2004) Differential alterations of receptor densities of three muscarinic acetylcholine receptor subtypes and current densities of the corresponding K+ channels in canine atria with atrial fibrillation induced by experimental congestive heart failure. Cell. Physiol. Biochem. 14:31-40.
8. Pönicke K, Heinroth-Hoffmann I, Brodde OE. (2003) Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats. Br. J. Pharmacol. 138:156-60.
9. Shi H, Wang H, Lu Y, Yang B, Wang Z. (1999) Choline modulates cardiac membrane repolarization by activating an M3 muscarinic receptor and its coupled K+ channel. J. Membr. Biol. 169:55-64.
10. Yue P, et al. (2006) Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricular myocytes. Cell. Physiol. Biochem. 17:129-36.
11. Wang H, Lu Y, Wang Z. (2007) Function of cardiac M3 receptors. Auton. Autacoid Pharmacol. 27:1-11.
12. Yang B, et al. (2005) Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors. Cell. Physiol. Biochem. 16:163-74.
13. Li GR, Lau CP, Leung TK, Nattel S. (2004) Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles. Heart Rhythm. 1:460-8.
14. Diaz RJ, et al. (2004) Selective inhibition of inward rectifier K+ channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes. Circ. Res. 95:325-32.
15. Xu Y, Zhang Q, Chiamvimonvat N. (2007) IK1 and cardiac hypoxia: after the long and short QT syndromes, what else can go wrong with the inward rectifier K+ currents? J. Mol. Cell. Cardiol. 43:15-7.
16. Dhamoon AS, Jalife J. (2005) The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis. Heart Rhythm. 2:316-24.
17. Beuckelmann DJ, Näbauer M, Erdmann E. (1993) Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ. Res. 73:379-85.
18. Ravens U, Cerbai E. (2008) Role of potassium currents in cardiac arrhythmias. Europace. 10:1133-7.
19. Divakaran V, Mann DL. (2008) The emerging role of microRNAs in cardiac remodeling and heart failure. Circ. Res. 103:1072-83.
20. Xie X, et al. (2005) Systematic discovery of regulatory motifs in human promoters and 3′UTRs by comparison of several mammals. Nature. 434:338-45.
21. Yang B, et al. (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13:486-91.
22. Arimoto T, et al. (2006) Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice. Circulation. 113:60-6.
23. Petzelbauer P, et al. (2005) The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat. Med. 11:298-304.
24. Zhang Y, et al. (2006) Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem. Biophys. Res. Commun. 340:1192-9.
25. Amran MS, Hashimoto K, Homma N. (2004) Effects of sodium-calcium exchange inhibitors, KBR7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies. J. Pharmacol. Exp. Ther. 310:83-9.
26. Willmy-Matthes P, Leineweber K, Wangemann T, Silber RE, Brodde OE. (2003) Existence of functional M3-muscarinic receptors in the human heart. Naunyn Schmiedebergs Arch. Pharmacol. 368:316-9.
27. Shi H, Wang H, Yang B, Xu D, Wang Z. (2004) The M3 receptor-mediated K(+) current (IKM3), a G(q) protein-coupled K(+) channel. J. Biol. Chem. 279:1774-2178.
28. Wang YP, et al. (2009) M3 muscarinic acetylcholine receptor is associated with beta-catenin in ventricular myocytes during myocardial infarction in the rat. Clin. Exp. Pharmacol. Physiol. 36:995-1001.
29. Liu Y, et al. (2009) Role of M3 receptor in aconi-tine/barium-chloride-induced preconditioning against arrhythmias in rats. Naunyn Schmiedebergs Arch. Pharmacol. 379:511-5.
30. Liu Y, et al. (2008) Choline produces antiarrhythmic actions in animal models by cardiac M3 receptors: improvement of intracellular Ca2+ handling as a common mechanism. Can. J. Physiol. Pharmacol. 86:860-5.
31. Zhao WM, et al. (2009) The antiarrhythmic effect and possible ionic mechanisms of pilocarpine on animal models. J. Cardiovasc. Pharmacol. Ther. 14:242-7.
32. de Bakker JM, van Rijen HV. (2007) Electrocardiographic manifestation of anatomical substrates underlying post-myocardial infarction tachycardias. J. Electrocardiol. 40:21-5.
33. Panama BK, McLerie M, Lopatin AN. (2007) Heterogeneity of IK1 in the mouse heart. Am. J. Physiol. Heart Circ. Physiol. 293:3558-67.
34. Fauconnier J, Lacampagne A, Rauzier JM, Vassort G, Richard S. (2005) Ca2+-dependent reduction of IK1 in rat ventricular cells: a novel paradigm for arrhythmia in heart failure? Cardiovasc. Res. 68:204-12.
35. Domenighetti AA, Boixel C, Cefai D, Abriel H, Pedrazzini T. (2007) Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation. J. Mol. Cell. Cardiol. 42:63-70.
36. Tomaselli GF, Marbán E. (1999) Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc. Res. 42:270-83.
37. Chen JF, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38:228-33.